SCHEMBL891102

SCHEMBL891102

[CH2]Cc1ccccc1CN

nearest known ligand 0.50

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
PNMT P11086 3/20 0.50
DPP4 P27487 3/20 0.46
LOXL2 Q9Y4K0 2/20 0.39
TAAR1 Q96RJ0 7/20 0.37
CYP2A6 P11509 1/20 0.37
KDM4E B2RXH2 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15247 0.85 PNMT (0.63) PNMTDPP4LOXL2TAAR1CYP2A6
SCHEMBL132297 0.85 HSPA5 (0.38) PNMTDPP4TAAR1CYP2A6
SCHEMBL29405036 0.85 PNMT (0.63) PNMTDPP4LOXL2TAAR1CYP2A6
SCHEMBL29212543 0.82 PNMT (0.60) PNMTDPP4LOXL2TAAR1CYP2A6
Hydrochloric Acid SCHEMBL30297049 0.82 PNMT (0.60) PNMTDPP4LOXL2TAAR1CYP2A6
Iodide SCHEMBL28958724 0.82 PNMT (0.60) PNMTDPP4LOXL2TAAR1CYP2A6
Hydrochloric Acid SCHEMBL2522138 0.82 PNMT (0.60) PNMTDPP4LOXL2TAAR1CYP2A6
Water SCHEMBL6142580 0.82 PNMT (0.60) PNMTDPP4LOXL2TAAR1CYP2A6
Hydrochloric Acid SCHEMBL31276815 0.82 PNMT (0.60) PNMTDPP4LOXL2TAAR1CYP2A6
Water SCHEMBL7618285 0.82 PNMT (0.60) PNMTDPP4LOXL2TAAR1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112867706-A MASP-2 inhibitors and methods of use 奥默罗斯公司 2021-05-28 CN claimed
EP-3802489-A2 MASP-2 INHIBITORS AND METHODS OF USE Omeros Corporation (US) 2021-04-14 EP claimed
CN-110392680-A Substituted azolyl pyrrolidones and azolyl hydantoins and salts thereof and their use as herbicidal active substances 拜耳作物科学股份公司 2019-10-29 CN claimed
EP-2510925-B1 Small-Molecule modulators of TRP-P8 activity DENDREON CORP (US) 2016-07-20 EP claimed
CN-102250458-B Poly carbonate resin composition and moulded product thereof CHEIL INDUSTRIES INC. (KR) 2016-01-27 CN claimed
US-20120083493-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2012-04-05 US claimed
CN-102250458-A Polycarbonate resin composition and molded product using the same CHEIL IND INC 2011-11-23 CN claimed
EP-2268273-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2011-01-05 EP claimed
CN-101798450-A Polylactic acid/polycarbonate resin composition and molded product made using the same CHEIL IND INC 2010-08-11 CN claimed
WO-2009067410-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2009-05-28 WO claimed
CN-101420942-A Small-molecule modulators of TRP-P8 activity DENDREON CORP (US) 2009-04-29 CN claimed
CN-101410366-A Substituted bicyclic ring derivatives and uses thereof ASAHI KASEI PHARMA CORP (JP) 2009-04-15 CN claimed
EP-1986622-A2 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2008-11-05 EP claimed
US-20080255185-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2008-10-16 US claimed
US-20070232603-A1 Small-molecule modulators of TRP-P8 activity DENDREON CORPORATION (US) 2007-10-04 US claimed
WO-2007095340-A2 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2007-08-23 WO claimed
CN-1119014-A Benzopyranes as potassium channel openers PFIZER LTD (GB) 1996-03-20 CN claimed
CN-117964683-A MASP-2 inhibitors and methods of use 奥默罗斯公司 2024-05-03 CN disclosed
CN-1024797-C Indole derivatives OTSUKA CHEMICAL CO LTD (JP) 1994-06-01 CN disclosed
CN-1049155-A INDOLE DERIVATIVES OTSUKA CHEMICAL CO LTD (JP) 1991-02-13 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232603-A1 Small-molecule modulators of TRP-P8 activity TRPC4, TRPC3, TRPC1 PNMT 3224/4885DPP4 2105/4885LOXL2 3109/4885
US-20080255185-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY TRPC4, TRPC3, TRPC1 PNMT 3224/4885DPP4 2105/4885LOXL2 3109/4885
US-20120083493-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY TRPC4, TRPC3, TRPC1 PNMT 3224/4885DPP4 2105/4885LOXL2 3109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.